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“ANTI-AGING-MEDICINE” FIELD: RESULTS FROM A
SYSTEMATIC HORIZON SCANNING
Storz P, Gothe H, Daroszewska A, Häussler B
IGES Institut GmbH, Berlin, Germany
OBJECTIVES: “Anti-Aging”, as an example of “preference ori-
ented medicine”, is a currently much debated ﬁeld. While it is
sometimes perceived as beneﬁcial in averting unwanted effects of
aging, improving quality of life and well-being, there is also
substantial criticism. The current investigation aims at providing
an overview on new health technologies of potential importance
for future “anti-aging” interventions. METHODS: The analysis
is based on the ZIM innovation database, which comprehen-
sively records developments related to new and emerging health
technologies. During the observation period from 2003 to 2007,
n = 15,552 datasets covering technological innovations in health
care could be identiﬁed from international publications and rel-
evant internet sources. In three broadly deﬁned application ﬁelds
(hormone therapy, cosmetics and interventions related to
improvement in cognition) upcoming health technologies were
identiﬁed from the database. Currently available technologies,
their intended use and potential future applications were
described. RESULTS: Regarding hormone therapy (n = 97 hits in
total) most frequently addressed indications were obesity
(n = 28), fertility (n = 15), contraception (n = 15), menopause
(n = 9), childhood growth (n = 8), and andropause (n = 6). Cos-
metic interventions (n = 47 in total) mostly addressed the treat-
ment of face (n = 20), skin (n = 13), and the female breast (n = 6).
Reports on cognition (n = 8) focused on the improvement of
the physical functioning (n = 5) or controlling of body parts/
prostheses (n = 3). For most technologies and applications,
however, it proved to be difﬁcult to distinguish a particular
“preference oriented” use from a potentially disease-related
assignment. CONCLUSIONS: Most innovations represent either
a minor improvement of an existing intervention or are still far
from possible routine use. Findings that speciﬁcally indicate
“preference based” applications were relatively rare. This leads
to the conclusion that research and development of new health
technologies primarily starts from a perceived demand for
serious diseases and clear-cut indications. Only subsequently
“preference oriented” uses may be addressed.
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OBJECTIVES: In the Dutch health care system, like many other
countries, the general practitioner (GP) plays a key role in secur-
ing equity and effectiveness in delivering health care. Nowadays,
GPs are often part of primary care centers and it is foreseen that
these centers will play an even more important role in future
health service delivery. A European comparison in nine different
countries concluded patients favour small practices and full time
GPs. The percentage of GPs working in small practices varies
between countries. In the UK the percentage is 16% whereas in
Belgium the percentage is 69% and in Netherlands the percent-
age is 39%. Continuity of care and access is highly appreciated
by patients. For instance, it has been shown that patients are
more satisﬁed with primary care if they always have the same GP
and if they experience short waiting times. Given the develop-
ment of larger primary care centers, people are hesitant if the
current GP service levels can be maintained. On the other hand,
an advantage of primary care centers is that they do offer mul-
tiple medical services like pharmacy and physiotherapy. The
purpose of this study was two-fold. First, it was questioned
which type of services is preferred by patients in three different
GP settings and if people would be willing to pay for these
services. Second, we wish to investigate differences between
patients in different GP settings. The selected GP settings were 1)
a single person GP practice (SP); 2) a healthservice with multiple
independent GPs (GP); and 3) a multi-disciplinary and compre-
hensive primary care center supervised by one management
(PCC). METHODS: A discrete choice experiment (DCE) was
carried out among 164 patients in the three different GP settings.
The DCE comprised 6 attributes including 1) time to appoint-
ment; 2) choice of time; 3) access by telephone; 4) consultation
time; 5) availability of other medical services and; 6) WTP.
Sample size for the DCE was estimated at about 45 patients in
each GP setting. The DCE included 6 attributes. The maximum
number of levels for an attribute was three, allowing 72 choice
combinations. The DCE survey used 15 random and 2 ﬁxed
choicesets. Following the DCE, all 164 and an extra group of 114
patients (278 in total) were interviewed by a research assistent.
Sampling was carried out to obtain equal group sizes (approx.
55) in each of the GP settings (SP, GP and PCC). DCE data were
analyzed using sawtooth software. This abstract reports the ﬁrst
preliminary analyses of the complete dataset. RESULTS: Socio-
economic (income and education) and demographic data (age
and gender) of patients in each of the GP settings were compa-
rable. The DCE showed preference for improved telephone ser-
vices and time to appointment as most important attributes.
Except for “time to appointment” no large differences were
found between the GP settings. Only patients in the GP group
accepted longer waiting times compared to SP and PCC. SP and
PCC patients did prefer to have access within 24 hours, whereas
GP patients accepted longer waiting times. Overall, most impor-
tant attributes were “time to appointment”, “access of service by
telephone” and “WTP”. The availability of pharmacy services
was preferred by all patients. About 50% of all patients werent
willing to pay for additional services. However, some 35% was
willing to pay an extra amount of €9 for each consult if they
would receive additional services. CONCLUSIONS: This study
shows a similar outcome compared to previous studies on access
to GP services. “Time to ﬁrst appointment” and “access by
telephone” are most important factors to consider by patients.
However, an interesting ﬁnding was that one third of all patients
were willing to pay for improved services. The DCE study didn’t
show big differences in preferences between patients in the dif-
ferent GP settings. In some aspects (e.g. accessability) the SP
scored better compared to PCC and GP.
PHP5
HEALTH LITERACY—AN ECONOMIC PERSPECTIVE:
A SYSTEMATIC REVIEW
Eichler K,Wieser S, Brügger U
Zurich University of Applied Sciences,Winterthur, Switzerland
OBJECTIVES: Health Literacy (HL) is an important skill for
health relevant decisions. Limited HL is associated with poorer
health outcomes but little is known about the economic impli-
cations of limited HL. We assessed 1) the costs of limited HL for
the health care system, and 2) the cost-effectiveness of interven-
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tions to improve limited HL. METHODS: Systematic review
with electronic database searches (MEDLINE, EMBASE,
PsycINFO, CINHAL and COCHRANE-Library; from 1980
through January 2008), screening of selected books and reference
lists, and expert contacts. We included observational and inter-
ventional studies that reported HL of participants as one
outcome measure. We included populations at high risk for low
HL as well as patients with 1) diabetes mellitus, or 2) hyperlipi-
demia. Studies were screened for eligibility, unclear cases were
discussed in a consensus meeting. We performed data extraction
and quality assessment; results were checked by a second
reviewer. RESULTS: We retrieved 2340 papers and included 10
studies for the ﬁnal analysis. On the health care system level, the
additional spending due to low HL corresponds to 3% to 5% of
the total health care costs (3 studies with data of more than
50,000 persons from U.S. and Swiss settings). The prevalence of
limited HL is considerable (range: 34% to 59%; 4 studies;
110,000 nationally representative persons). Three U.S. studies
(data of 3600 persons) report the additional costs of limited HL
on the patient level (additional expenditures per year per person
with limited HL compared to a reference group with adequate
HL; range: US $143 to 7798). One systematic review reported
cost-effectiveness data of patient self management programs for
diabetes and showed inconclusive results. CONCLUSIONS: The
costs of limited HL for the health care system may be substantial,
but few studies were retrieved, and the results are heterogeneous.
HEALTH CARE USE & POLICY STUDIES—
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CLINICAL AND ECONOMIC OUTCOME OF MECHANICALLY
VENTILATED PATIENTS UNDER DRG 483 IN SPAIN:
A POPULATION-BASED STUDY
Bouza C, Lopez T, Muñoz R
Carlos III Health Institute, Madrid, Spain
OBJECTIVES: To analyze the costs and discharge status for
patients with prolonged mechanical ventilation undergoing tra-
cheostomy (DRG code 483) in Spain and to examine the impact of
age in terms of hospital outcome. METHODS: From the
2004 National Hospital Discharge Database records for all
patients aged >16 years undergoing mechanical ventilation were
retrieved. Demographic characteristics, clinical outcomes and
hospital-resources utilization were examined. An exploratory
logistic regression analysis and a multiple linear regression analy-
sis were performed to identify factors associated with in-hospital
mortality and LOS respectively. To depict the amount of resources
spent to procure a given level of desired outcome (hospital sur-
vival) we also determined the cost per survivor based in the
average National Health Service Charges for DRG 483
(€49,365.37).RESULTS: From a total of 33,416 cases undergoing
mechanical ventilation during 2004, 4,277 cases (13%) with a
ﬁnal DRG code of 483 were selected and eligible for analysis.
Median age was 65 yr (p25:50; p75:73); 67%were men and 54%
surgical patients. According to Charlson index, 56% of cases had
no associated comorbidity. Overall in-hospital mortality was
41%. Total costs of hospitalizations exceeded € 211 million. An
inverse relationship between survival rate and age was consis-
tently observed after adjusting by other clinical variables, and this
resulted in an age-related increased cost per survivor (€58,588 in
patients aged <45 yrs; €75,1531 in those aged 45–64 yrs; 99,720
in 65–74 yrs and €12,5903 in those older than 74 yrs).CONCLU-
SIONS: Patients who require tracheostomy for prolonged
mechanical ventilation have high resource utilization and rela-
tively poor outcomes. Age has a signiﬁcant impact on outcomes in
patients under DRG 483 both from clinical and economic per-
spectives. These analyses will help inform health care decision-
making and resource planning in the face of an ageing population.
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OBJECTIVES: In the Hungarian DRG system it can frequently
occur that real costs exceed the amount of reimbursements. Our
goal was to compare the difference between the real clinical cost
and the normative DRG reimbursement in a single patient case.
METHODS: Data derive from the ﬁnancial database of the
National Health Insurance Fund Administration (NHIFA) and
the clinical database of the University of Pecs. We made an outlay
of the patient’s variable costs for drugs, infusions, nutritive prod-
ucts, transfusions, laboratory diagnostics and imagining proce-
dures used. The results we obtained were compared to standards
calculated by the NHIFA for the surgical treatment of oesoph-
ageal cancer. The case was grouped to DRG code number 9540
which had 13.2 weight-number. RESULTS: The weight-number
of medication components in this DRG category was 1.68
(12.7% of the total 13.2 weight-number). The real medication
cost was HUF 3,960,000 which represented 39.6 weight-number.
This exceeded the DRG medication reimbursement 23.6 times
and was 3 times more than the total reimbursement. In this way
just the medication cost was 300% of the total DRG ﬁnancing.
The excess cost was generated by increased drug usage due to
the patient’s severe septic complications. The main elements of
medications were a four-day activated protenine-C treatment
representing 53.5% of total drug expenditure, IgM enriched
polyclonal antibody therapy (28.4%) and 5 different antibiotics
(7.24%). The treatment of severe sepsis made up 89.1% of total
medication cost. As an excess, 27.6 weight-number was reim-
bursed topping the 13.2 weight-number for the original DRG.
CONCLUSIONS: There was a signiﬁcant gap between real hos-
pital costs and health insurance reimbursement. On the basis of
this analysis, the NHIFA found our demand for extra ﬁnance
justiﬁed and reimbursed our institution with the extra cost
applied for. Our case signiﬁcantly contributed to regulation
changes dealing with extra ﬁnancing for outlayer patient’s costs
in the DRG system.
PHP8
ADVERSE DRUG REACTIONS IN GERMANY: COST ANALYSIS
OF INTERNAL MEDICINE HOSPITALIZATIONS
Rottenkolber D1, Rottenkolber M2, Schmiedl S3, Szymanski J3,
Hasford J2
1Munich Center of Health Sciences, Munich, Germany,
2Ludwig-Maximilians-Universität, Munich, Germany, 3University of
Witten/Herdecke, HELIOS Klinikum Wuppertal,Wuppertal, Germany
OBJECTIVES: German hospital reimbursement changed signiﬁ-
cantly as a result of the introduction of Diagnosis Related
Groups (DRG) in the year 2004. Based on this development no
current data on the direct costs of adverse drug reactions (ADR)
leading to hospital admissions in departments of internal
medicine is available. The objective of our project is to quantify
the ADR-related economic burden of the respective ADRs in
Germany. METHODS: A total of 1242 patient records of ADRs
leading to internal medicine hospitalization were surveyed in 4
regional pharmacovigilance centres in Germany within the years
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